Discover
MYGN
Myriad Genetics, Inc.
3.22
1 x 3.10
3 x 3.45
bid
ask
-
0.03
0.92%
1 @ 04:00 PM
3.22 +0.00 (0.00%)
| Ytd | -47.64% | |
| 1y | -47.98% |
3.15
day range
3.27
2.74
52 week range
8.59
| Open | 3.23 | Prev Close | 3.25 | Low | 3.15 | High | 3.27 | Mkt Cap | 304.12M |
| Vol | 1.46M | Avg Vol | 1.93M | EPS | -0.13 | P/E | -24.77 | Forward P/E | 71.53 |
| Beta | 1.89 | Short Ratio | 4.83 | Inst. Own | 103.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 4.95 | 200-d Avg | 5.45 | 1yr Est | 19.41 |
| Income Statement | |||
| Total Revenue | 190.70M | ||
| Revenues (USD) | 190.70M | ||
| Cost of Revenue | 63.70M | ||
| Gross Profit | 127.00M | ||
| Operating Expenses | 165.90M | ||
| Research and Development Expense | 25.00M | ||
| Selling, General and Administrative Expense | 140.90M | ||
| Operating Income | -38.90M | ||
| Interest Expense | 4.10M | ||
| Income Tax Expense | 600.00K | ||
| Net Income | -43.20M | ||
| Net Income Common Stock | -43.20M | ||
| Net Income Common Stock (USD) | -43.20M | ||
| Consolidated Income | -43.20M | ||
| Earnings per Basic Share | -0.46 | ||
| Earnings per Basic Share (USD) | -0.46 | ||
| Earnings per Diluted Share | -0.46 | ||
| Earning Before Interest & Taxes (EBIT) | -38.50M | ||
| Earning Before Interest & Taxes (USD) | -38.50M | ||
| Weighted Average Shares | 94.80M | ||
| Weighted Average Shares Diluted | 94.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 115.20M | ||
| Cash and Equivalents (USD) | 115.20M | ||
| Trade and Non-Trade Receivables | 109.50M | ||
| Current Assets | 289.00M | ||
| Property, Plant & Equipment Net | 158.90M | ||
| Total Assets | 638.90M | ||
| Debt Current | 7.30M | ||
| Total Debt | 210.50M | ||
| Current Liabilities | 130.70M | ||
| Debt Non-Current | 203.20M | ||
| Total Liabilities | 335.00M | ||
| Accumulated Retained Earnings (Deficit) | -1.20B | ||
| Accumulated Other Comprehensive Income | 800.00K | ||
| Shareholders Equity | 303.90M | ||
| Shareholders Equity (USD) | 303.90M | ||
| Assets Non-Current | 349.90M | ||
| Total Debt (USD) | 210.50M | ||
| Goodwill and Intangible Assets | 186.10M | ||
| Inventory | 30.60M | ||
| Liabilities Non-Current | 204.30M | ||
| Trade and Non-Trade Payables | 30.40M | ||
| Tax Assets | 1.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.60M | ||
| Net Cash Flow from Financing | 2.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.20M | ||
| Capital Expenditure | -3.20M | ||
| Issuance (Purchase) of Equity Shares | 2.80M | ||
| Issuance (Repayment) of Debt Securities | -200.00K | ||
| Net Cash Flow from Investing | -3.20M | ||
| Net Cash Flow from Operations | -8.30M | ||
| Effect of Exchange Rate Changes on Cash | 100.00K | ||
| Share Based Compensation | 7.20M | ||